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Abstract
Background: The stability of the accuracy of a diagnostic test is critical to whether clinicians can rely on its result. We aimed
to assess whether the performance of a rapid antigen detection test (RADT) for group A streptococcus (GAS) is affected by
the clinical spectrum and/or bacterial inoculum size.
Methods: Throat swabs were collected from 785 children with pharyngitis in an office-based, prospective, multicenter study
(2009–2010). We analysed the effect of clinical spectrum (i.e., the McIsaac score and its components) and inoculum size
(light or heavy GAS growth) on the accuracy (sensitivity, specificity, likelihood ratios and predictive values) of a RADT, with
laboratory throat culture as the reference test. We also evaluated the accuracy of a McIsaac-score–based decision rule.
Results: GAS prevalence was 36% (95CI: 33%–40%). The inoculum was heavy for 85% of cases (81%–89%). We found a
significant spectrum effect on sensitivity, specificity, likelihood ratios and positive predictive value (p,0.05) but not
negative predictive value, which was stable at about 92%. RADT sensitivity was greater for children with heavy than light
inoculum (95% vs. 40%, p,0.001). After stratification by inoculum size, the spectrum effect on RADT sensitivity was
significant only in patients with light inoculum, on univariate and multivariate analysis. The McIsaac-score–based decision
rule had 99% (97%–100%) sensitivity and 52% (48%–57%) specificity.
Conclusions: Variations in RADT sensitivity only occur in patients with light inocula. Because the spectrum effect does not
affect the negative predictive value of the test, clinicians who want to rule out GAS can rely on negative RADT results
regardless of clinical features if they accept that about 10% of children with negative RADT results will have a positive throat
culture. However, such a policy is more acceptable in populations with very low incidence of complications of GAS infection.
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Introduction
Group A streptococcus (GAS) is found in 20% to 40% of cases
of childhood pharyngitis; the remaining cases are considered viral
[1]. Clinical examination cannot distinguish accurately between
viral and GAS pharyngitis [2], and a diagnostic test based on a
throat swab is recommended in most countries [3]. Throat culture
on a blood agar plate in a microbiology laboratory for 48 hours is
the reference test for diagnosis of GAS pharyngitis [4–7]. Rapid
antigen detection tests (RADTs) have been proposed as an
alternative to throat culture. Compared to laboratory culture,
RADTs have high specificity (<95%) and results are immediate.
Their main drawbacks are low sensitivity (<85%, range 65.6% to
98.9%) [8,9] and variations in sensitivity by clinical spectrum of
the disease (spectrum effect, or spectrum bias) [10–12]. The major
issue for the spectrum effect is the generalisability of test
performance. First, the overall population estimate might not be
generalisable to patient subpopulations; second, the diagnostic
accuracy that was observed in one study might not be applicable to
other patients. Three studies have shown a significant spectrum
effect on RADT sensitivity, but these studies had methodological
limitations suggesting selection, indication, partial verification, and
measurement biases [13–15]. No studies investigated the effect of
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clinical spectrum on sensitivity, specificity, likelihood ratios and
predictive values of RADTs at the same time [13–15]. As well,
RADT sensitivity is affected by inoculum size [16–18] – the
amount of GAS colonies identified on throat culture and
considered a proxy of the bacterial load on the swab. In vitro,
the threshold of positivity of RADTs is between 105 and 107
colony-forming units per ml [19]. To date, several studies
evaluated the effects of clinical spectrum and inoculum size on
RADT sensitivity, but these effects were studied only separately,
and no study has analysed the potential relation of clinical
spectrum and inoculum size.
Because of the need to reduce antibiotics consumption, clinical
decision rules were developed to help clinicians determine which
patients should undergo testing and/or treatment with antibiotics.
A decision rule based on the McIsaac score was recently proposed
for adults and children [20–22], but this McIsaac-score–strategy
was insufficiently validated in children [21–23]. In one validation
study by McIsaac et al., the reader cannot evaluate the risk of
selection bias because the distribution of scores in children was not
reported [21]. Another validation study did not include children
with low-risk scores (score #1) [22]. A third study aimed to
validate the McIsaac score in children, but the rule was modified
for application in low-resource settings and no longer integrated
the use of a throat culture or RADT [23].
We aimed to determine whether the diagnostic accuracy of a
RADT for GAS pharyngitis is affected by the clinical spectrum
effect and/or bacterial inoculum size and to validate a McIsaac-
score–based decision rule.
Methods
Study Design
This is a secondary analysis of data from an office-based,
multicenter, prospective study that took place in France between
October 2009 and June 2011 (unpublished data). The aims of the
princeps study were to evaluate the frequency of GAS carriage in
healthy children and to compare the performance of a RADT
between children with pharyngitis and healthy children, with
throat culture in a microbiology laboratory as the reference test
(intermediate results presented at the 28th Annual Meeting of The
European Society for Paediatric Infectious Diseases, Nice, France,
2010; abstract A-229-0021-00920). This ancillary analysis was
restricted to patients with pharyngitis from the first year of
inclusion. The STARD statement was followed for reporting the
results of the study [24].
Patients
Eligible patients were 3 to 15 years old who were evaluated by
their paediatrician between October 2009 and May 2010, who
had a diagnosis of pharyngitis and did not receive antibiotics for 7
days before inclusion. Pharyngitis was defined by inflammation of
the pharynx and/or tonsils. In total, 17 French paediatricians who
are part of a research and teaching network (ACTIV) participated
in the study [25].
Throat Swabs
Throat samples were obtained by use of a double–swab
collection–transportation system (Venturi Transystem Amies agar,
COPAN Diagnostics, Corona, CA, USA). The RADT (StreptAt-
est, Dectrapharm, France), a GAS-specific immuno-chromato-
graphic strip assay, was performed immediately with swab #1
collected in the paediatrician’s office. Swab #2 was held at
ambient temperature and sent within 72 hr to the Robert Debre´
Hospital laboratory by an express messenger service. On receipt,
the swab was rolled over one-quarter of a trypticase soy agar plate
with 5% sheep blood, and the inoculum was further distributed on
the plate by streaking with a sterile wire loop. The plates were
incubated anaerobically at 37uC and read after 18 to 24 hr.
Negative cultures were reexamined after an additional 24 hr of
incubation (48 hr total). ß-haemolytic colonies were further
investigated by latex agglutination (Prolex, Pro-Lab Diagnostics,
Richmond Hill, ON, Canada). With GAS positivity, inoculum size
was estimated as follows: 1+, ,10 colonies; 2+, 11–50 colonies;
and 3+, .50 colonies per plate. Data for patients with 1+ and 2+
cultures were combined to produce a dichotomized variable (light
or heavy GAS growth). Microbiologists were blinded to individual
clinical data and RADT results.
Clinical Data
We collected clinical data needed to calculate the McIsaac score
for each patient. The McIsaac score predicts GAS pharyngitis and
ranges from 0 to 5 [20–22]. McIsaac criteria include age 3 to 15
years, history of fever, tonsillar swelling or exudate, tender anterior
cervical adenopathy, and absence of cough. As for other studies
[13,26], the adenopathy criterion was modified to include any
anterior cervical adenopathy $1 cm and/or presence of tender-
ness because tender lymph nodes can be difficult to assess in
children. As for other authors [13–15], extreme McIsaac scores
were combined (scores 1 and 2, and 4 and 5), and for analysis of
clinical components of the score, age was re-coded into 2
categories of equal range (3–8 years; 9–14 years).
Sample Size
In the original study, sample size was estimated so that the 95%
confidence interval (95CI) for RADT sensitivity would be a +/
25% estimation. Assuming sensitivity to vary between 75% and
95% and a GAS prevalence of 35%, a sample of 714 children with
pharyngitis was needed. No other sample size calculation was
performed for this secondary analysis.
Ethics
The study protocol was approved by the Institutional Review
Board Comite´ de Protection des Personnes Ile-de-France XI
(nu09016) and the French administrative authorities (CNIL,
nu1354254; Afssaps, nu2009-A00086-51). Parent and patient
approval for participation was obtained before inclusion. Data
were double entered into 4D software version 6.4 (4D) and the
database was fully anonymized.
Statistical Analysis
Hospital laboratory throat culture was considered the reference
test. First, we described patient demographic features and overall
prevalence of groups A, C and G b-haemolytic streptococci.
Patients with group C or G b-haemolytic streptococci were
considered GAS-negative in the analysis. Then, GAS prevalence
by McIsaac score and each McIsaac criterion were described.
Second, we used chi-square tests to investigate the clinical
spectrum effect on RADT diagnostic accuracy (sensitivity,
specificity, likelihood ratios and predictive values) by McIsaac
score and each McIsaac criterion. Third, chi-square tests were
used to compare the distribution of GAS inoculum size by office-
to-laboratory delay (#48 vs. .48 hr) and to study the effect of
inoculum size (light or heavy GAS growth) on RADT sensitivity.
Fourth, the distribution of heavy inocula by McIsaac score was
explored by a chi-square test for trend, and the association of
clinical signs and inoculum size was evaluated by comparing the
frequency of heavy inoculum according to each clinical criterion
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by chi-square tests. Fifth, a binomial model with an identity link
was used to evaluate the combination of clinical spectrum effect
and inoculum size on RADT sensitivity [27]. Differences in
RADT sensitivity were estimated by restricting the analysis to
patients with a positive throat culture and using the result of the
RADT as the outcome in the model. RADT sensitivity was
investigated by univariate modeling according to each McIsaac
criterion and then, multivariate modeling by all McIsaac criteria
and inoculum size. Potential interaction between inoculum size
and each McIsaac criterion was assessed by use of a Wald test. For
multivariate modeling, variables were added one by one following
the crescent univariate statistical significance order until non-
convergence of the model. Significant interactions were managed
by introducing corresponding interaction terms in the multivariate
model and, in case of non-convergence, by stratification on
inoculum size. Sixth, the accuracy of the following McIsaac-score–
based decision rule was studied in terms of sensitivity and
specificity: (a) scores ,2, no further testing or antibiotic; (b) scores
2–3, culture all, antibiotics only with positive culture; (c) scores$4,
treat empirically with antibiotics [22]. Statistical analysis involved
use of Stata/SE 12 (StataCorp, College Station, TX, USA).
Results
Population Characteristics, GAS Prevalence
In total, 807 children met the inclusion criteria; 1 patient with
unreadable RADT results, 2 with lost throat swabs and 19 with
missing data for McIsaac score calculation were secondarily
excluded. Therefore, analysis involved 785 children (351 girls
[44.7%]), with mean (SD) age 6.1 (2.5) years. Overall, GAS
prevalence was 36.3% (95CI, 32.9%–39.8%). In all, 4 (,1%)
Group C and 7 (,1%) Group G b-haemolytic streptococci were
identified on BAP. The mean age of secondarily excluded children
was 5.9 (3.0) years and GAS was found in throat cultures for 4/20
(20.0% [7.9%–39.2%]).
GAS prevalence increased with increasing McIsaac score
(p,0.001) (Tables 1 and 2), from 24.3% to 41.2% for children
with#2 and$4 McIsaac score, respectively. Some clinical criteria
were also associated with GAS: age ,9 years, absence of cough,
and presence of fever (Table 2).
Spectrum Effect
Overall, the sensitivity and specificity of the RADT was 86.7%
(82.2%–90.4%) and 94.6% (92.2%–96.4%), respectively; positive
and negative likelihood ratios 16.1 (11.1–23.2) and 0.14 (0.10–
0.19), respectively; and positive and negative predictive values
90.1% (86.0%–93.4%) and 92.6% (89.9%–94.7%), respectively.
We found significant variations in RADT sensitivity and
specificity by McIsaac score (Table 2). Sensitivity increased from
75% (55.1%–89.3%) to 84.3% (75.0%–91.1%) and to 89.9%
(84.3%–94.0%; p = 0.02), and specificity decreased from 97.7%
(91.9%–99.7%) to 96.0% (91.8%–98.4%) and to 92.5% (88.4%–
95.5%; p = 0.04) with McIsaac scores #2, 3 and $4, respectively
(Table 2). RADT likelihood ratios and predictive values varied,
but not significantly, by McIsaac score.
The RADT performance varied significantly by McIsaac
criteria. For example, sensitivity was significantly lower in children
$9 years old than in younger children (66.7% [47.2%–82.7%] vs.
89.0% [84.5%–92.6%], p,0.01). The negative predictive value
varied, but not significantly, by McIsaac score or clinical criteria,
ranging from 88.8% (80.8%–94.3%) for children without tonsillar
swelling or exudate to 94.6% (90.0%–97.5%) for children without
fever.
Effect of Inoculum Size on RADT Sensitivity
Among 285 GAS-positive throat cultures, 243 (85% [80.6%–
89.2%]) showed heavy inoculum. The distribution of inoculum
size did not differ by office-to-laboratory delay (#48 vs..48 hr, p
= 0.97). RADT sensitivity varied widely and significantly between
patients with light and heavy inoculum (40.5% [25.6%–56.7%] vs.
94.7% [91.0%–97.1%], p,0.001). Light inoculum was found in
65.8% (50.0%–81.6%) of false-negative RADT cases versus 6.9%
(3.7%–10.1%) of true-positive cases (p,0.001).
Frequency of heavy inocula increased with increasing McIsaac
score, although not significantly (p = 0.09, table 1). Heavy
inoculum was significantly more frequent in children ,9 years
old than in older children (87.1% [82.9%–91.2%] vs. 70.0%
[52.6%–87.4%], p,0.05).
Combined Effect of Clinical Spectrum and Inoculum Size
The results of univariate binomial modeling for RADT
sensitivity were almost identical to those of stratified analysis
(Tables 2 and 3): age $9 years and presence of cough were
significantly associated with decreased RADT sensitivity (p,0.05).
After stratification on inoculum size, wide and statistically
significant variations in RADT sensitivity were found in patients
with light inoculum (e.g., 37.4% variation in sensitivity by age,
p,0.01), but not widely (,6%) nor significantly in patients with
heavy inoculum. Interactions were found between inoculum size
and age (p = 0.03), anterior cervical adenopathy (p = 0.01), and
tonsillar swelling or exudate (p = 0.07).
Because of these multiple interactions and because of no
convergence in the multivariate model after introducing interac-
tion terms, 2 multivariate models of RADT sensitivity were fit by
stratifying on inoculum size (Table 3). Results of multivariate
modeling were close to those of univariate modeling. Light
inoculum was associated with wide and statistically significant
adjusted variation in RADT sensitivity (e.g., from 23.6% to
40.9%), but heavy inoculum was not widely (#6%) or significantly
associated.
Table 1. Distribution of the McIsaac scores and
corresponding frequencies of positive results of rapid antigen
detection test (RADT), group A streptococcus (GAS) and heavy
GAS inocula (N = 785).
n (%)
McIsaac
scorea Total
RADT
-positive
GAS
-positiveb
Heavy
inoculumc
1 12 (1) 2/12 (17) 3/12 (25) 2/3 (67)
2 103 (13) 21/103 (20) 25/103 (24) 20/25 (80)
3 262 (33) 82/262 (31) 89/262 (34) 73/89 (82)
4 286 (36) 115/286 (40) 114/286 (40) 100/114 (88)
5 122 (16) 54/122 (44) 54/122 (44) 48/54 (89)
aAll scores were $1 because all included patients were 3 to 15 years old.
bLaboratory throat culture positive for GAS.
cp = 0.09, x2 test for trend for the frequency of heavy inoculum by McIsaac
score.
doi:10.1371/journal.pone.0039085.t001
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Performance of the McIsaac-score–based Decision Rule
Among 785 children, 522 (66%) would have received antibiotics
according to the decision rule. The rule had 98.9% (97.0%–
99.8%) sensitivity and 52.0% (47.5%–56.5%) specificity.
Discussion
Accuracy of a diagnostic test can vary across patient subgroups
within a population, a phenomenon referred to as spectrum effect
(or spectrum bias) [10–12]. In assessing the relation of clinical
spectrum and inoculum size with RADT performance for GAS
pharyngitis, we confirm that the spectrum effect has an impact on
RADT sensitivity and report for the first time that it also affects the
specificity, likelihood ratios and positive predictive value of the
test. However, the spectrum effect had no impact on the negative
predictive value of the RADT, which remained stable at about
92%, regardless of McIsaac score or its components. Clinicians do
not want to expose their patients to GAS suppurative and
nonsuppurative complications by withholding antibiotic treatment
and therefore need a diagnostic test with high, stable negative
predictive value. In this population with a GAS prevalence of
36%, a patient with a negative RADT result had a probability of
GAS-positive throat culture close to 8% regardless of clinical
features.
This study confirms the important effect of inoculum size on
RADT sensitivity, already described in other studies, and reports
for the first time an association of clinical spectrum and inoculum
size. Our data suggest that having more streptococci in the throat
(greater inoculum size) might be associated with more intense
symptoms (higher McIsaac score) (p = 0.09), although we might
not have had enough statistical power to validate this hypothesis.
However, because we were not able to differentiate GAS carriers
from truly infected patients (i.e., by assessment of streptococcal
antibody response) [16,28], we cannot conclude on whether these
patients with low McIsaac scores and light inocula were more
likely to be GAS carriers rather than truly infected patients.
We chose to investigate the McIsaac score in 3 categories rather
than compare the accuracy of the RADT above and below a
defined breakpoint [15] because this corresponds to the original
aims of the score – to stratify patients into 3 levels of risk and to
suggest a subsequent course of action (low-risk: no test, no
antibiotics; intermediate risk: culture or RADT, antibiotics only
for positive results; high-risk: empirical antibiotic treatment
without testing) [20–22]. According to our results, the McIsaac
score alone does not allow for ruling out or affirming the diagnosis
of GAS pharyngitis because the reported GAS prevalence ranged
from 25% (too-high level to rule out) to 44% (too-low level to
affirm) in children with a score of 1 and 5, respectively. Moreover,
the McIsaac-score–based decision rule had only 52.0% (47.5%–
56.5%) specificity, which does not seem consistent with the current
need to reduce antibiotic consumption to contain antimicrobial
resistance.
One of the strengths of this study is its prospective, multicenter
design, which limits the selection bias potentially present in other
studies [13,14]. All included children underwent RADT and
laboratory culture, which excluded the possible indication and
Table 3. Analysis of combined spectrum and inoculum size effect on sensitivity of rapid antigen detection test (RADT).
Univariate analysisa Multivariate analysisa
Variable All inocula p Light inoculum p Heavy inoculum p pb
Light
inoculumc p
Heavy
inoculumd p
(n = 285) (n =42) (n =243) (n =42) (n =243)
Age (years)
3–8 ref 0.01 ref ,0.01 ref 0.49 0.03 ref ,0.001 ref 0.36
9–14 222.4 (239.7; 25.1) 237.4 (264.1; 210.7) 24.6 (217.4; 8.3) 240.9 (257.9;
224.0)
25.7 (217.9; 6.4)
Lack of cough
Yes ref 0.03 ref 0.09 ref 0.14 0.19 ref ,0.001 ref 0.08
No 210.0 (219.1; 29.0) 225.0 (253.6; 3.6) 25.2 (212.1; 1.7) 223.6 (223.7;
223.5)
26.0 (212.5; 0.6)
Anterior cervical adenopathy
No ref 0.07 ref 0.01 ref 0.88 0.01 ref 0.01 ref 0.37
Yes 7.3 (20.6; 15.2) 36.1 (7.7; 64.5) 20.4 (26.1; 5.2) 40.5 (16.7; 64.3) 2.0 (22.3; 6.2)
Tonsillar swelling or exudate
No ref 0.40 ref 0.12 ref 0.21 0.07 n/ae ref 0.29
Yes 4.3 (25.6; 14.3) 225.0 (256.2; 6.2) 5.4 (23.1; 13.9) 4.0 (23.4; 11.4)
Fever
No ref 0.61 ref 0.27 ref 0.77 0.26 n/ae ref 0.41
Yes 22.3 (210.8; 6.3) 219.1 (253.0; 14.8) 1.0 (25.6; 7.6) 2.3 (23.3; 8.0)
Data RADT sensitivity difference (95% confidence interval) unless indicated.
Abbreviations: ref, reference; n/a, not applicable.
aBinomial modelling.
bInteraction test between clinical variables and inoculum size (Wald test).
cModel adjusted on age, lack of cough, anterior cervical adenopathy.
dModel adjusted on age, lack of cough, anterior cervical adenopathy, tonsillar swelling or exudate and fever.
eNot included in the model because of non-convergence.
doi:10.1371/journal.pone.0039085.t003
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verification biases of other studies [13,14]. The results of our study
are close to those reported in the literature. GAS prevalence was
36.3% (32.9%–39.8%), which is close to that from a recent meta-
analysis (37%, 32%–43%) [1]. The overall RADT sensitivity was
86.7% (82.2%–90.4%), which is close to that from another recent
meta-analysis (85%, 84%–87%) [9]. A limitation is that we used a
modified adenopathy criterion for the analyses. However,
univariate and multivariate modeling results and the performance
of the McIsaac-score-based decision rule were stable in a sensitivity
analysis involving the original McIsaac adenopathy criterion
instead of our modified criterion.
Another limitation to our study is that some throat swabs were
plated .48 hr after collection. This delay had no significant effect
on the distribution of GAS inocula, but prolonged or inadequate
shipping conditions could have resulted in the loss of viability of
GAS if the original swab had only small numbers of bacteria.
Therefore, some swabs with light inocula could have been falsely
read as negative on throat culture. Because RADTs are more
likely to give negative results with light inocula, these swabs might
have led to a systematic decrease in number of RADT false-
negative results and systematic increase in number of RADT true-
negative results, with over-estimation of the negative predictive
value of the RADT as a result. We can assume that this bias
occurred at random because shipping and all bacteriologic
investigations were blinded to clinical data and RADT results –
non-differential measurement bias. Such a bias usually leads to loss
of power, and our results regarding the stability of the negative
predictive value of the RADT should be considered with caution
until they are confirmed with a larger sample of patients.
The American Academy of Pediatrics advises that ‘‘Children with
manifestations highly suggestive of viral infection […] generally should not be
tested for GAS infection’’ [7]. Such guidelines cannot be formally
validated because the criteria proposed to determine patients who
should be tested are not integrated in an explicit decision rule and
remain subject to personal interpretation. Because of GAS
carriage and because GAS complications have become uncom-
mon in North America and Western Europe [29], we advocate
that the target sensitivity of diagnostic strategies for GAS
pharyngitis should not be 100%. Moreover, discussions should
not focus on sensitivity alone. We showed that the negative
predictive value of a test can be stable across patient subgroups
because variations in prevalence can be balanced by concomitant
variations in sensitivity and specificity. Therefore, clinicians who
want to rule out GAS can rely on negative RADT results
regardless of clinical features if they accept that about 10% of
children with negative RADT results will have a positive throat
culture. However, these results should be considered with caution
because they depend highly on the study population, the training
of clinical and laboratory personnel and the microbiological
devices and protocols used. Moreover, available data suggest that
false-negative RADT results are as likely to occur in truly infected
patients as in GAS carriers [16,28]. Therefore, such a policy would
be more acceptable in populations with very low incidence of
suppurative and non-suppurative complications of GAS infection
[30]. The McIsaac-score–based decision rule is insufficiently
accurate for children, and efforts are needed to develop more
specific selective testing strategies for GAS pharyngitis in children.
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